Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Currax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Onzetra
Sumatriptan
2016-01-27
2024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
Silenor
Doxepin
2010-03-17
2027-2030
Atopic dermatitis
,
Pruritus
,
Pain
,
Anxiety disorders
,
Psychotic affective disorders
,
Depressive disorder
Treximet
Naproxen
,
Sumatriptan
2008-04-15
2025-2026
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
,
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Nausea
,
Sleep initiation and maintenance disorders
,
Allergic rhinitis perennial
,
Urticaria
,
Motion sickness
,
Sneezing
,
Anxiety disorders
,
Sinusitis
,
Asthma
,
Stomach ulcer
,
Migraine disorders
,
Cluster headache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Naproxen
migraine disorders
Sumatriptan
healthy volunteers/patients
Doxepin
ataxia
,
healthy volunteers/patients
Benzocaine
type 1 diabetes mellitus
,
neoplasms
,
hypoglycemia
,
liver diseases
,
type 2 diabetes mellitus
,
hepatitis c
,
hepatitis
,
hepatitis a
,
movement disorders
,
central nervous system diseases
,
brain diseases
,
neurodegenerative diseases
,
glucose metabolism disorders
,
metabolic diseases
,
endocrine system diseases
,
drug-induced akathisia
,
nervous system diseases
,
chronic hepatitis
,
parkinsonian disorders
,
drug-induced dyskinesia
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
liver cirrhosis
,
fibrosis
,
hiv
,
castration-resistant prostatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
alzheimer disease
,
dementia
,
thyroid neoplasms
,
thyroid diseases
,
parkinson disease
,
diabetes mellitus
,
chronic hepatitis c
,
hiv infections
,
acquired immunodeficiency syndrome
,
hiv-2
,
immunologic deficiency syndromes
,
small cell lung carcinoma
,
hypertension
,
coronary artery disease
,
myocardial ischemia
,
dyslipidemias
,
atherosclerosis
,
rheumatoid arthritis
,
arthritis
,
neuromuscular blockade
,
prostatic neoplasms
,
anesthesia
,
obesity
,
chronic renal insufficiency
,
acute coronary syndrome
,
kidney diseases
,
leiomyoma
,
endometriosis
,
cholecystitis
,
uterine prolapse
,
intestinal obstruction
,
prolapse
,
spinal diseases
,
delayed emergence from anesthesia
,
laryngoscopy
,
laparoscopy
,
muscle relaxation
,
disease
,
gastric bypass
,
respiration
,
urinary retention
,
infertility
,
female infertility
,
uterine diseases
,
postoperative complications
,
pneumonia
,
wound infection
,
surgical wound infection
Lorcaserin
healthy volunteers/patients
,
marijuana abuse
,
breast neoplasms
,
digestive system neoplasms
,
peripheral nervous system diseases
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
hypertension
,
dyslipidemias
,
sleep apnea syndromes
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
seizures
,
obesity
,
weight loss
,
overweight
,
cardiovascular diseases
,
weight gain
,
body weight
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
drug resistant epilepsy
Histone-arginine methyltransferase carm1
pain
,
diabetic neuropathies
Prudoxin
ataxia
,
healthy volunteers/patients
Lorcaserin hydrochloride anhydrous
healthy volunteers/patients
,
marijuana abuse
,
breast neoplasms
,
digestive system neoplasms
,
peripheral nervous system diseases
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
hypertension
,
dyslipidemias
,
sleep apnea syndromes
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
seizures
,
obesity
,
weight loss
,
overweight
,
cardiovascular diseases
,
weight gain
,
body weight
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
drug resistant epilepsy
Surlorian
head and neck neoplasms
,
prostatic neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
macular degeneration
,
macular edema
,
edema
,
pancreatic ductal carcinoma
,
adenocarcinoma
,
melanoma
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
chronic progressive multiple sclerosis
,
sclerosis
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
Lorcaserin hydrochloride hemihydrate
obesity
Isoxaflutole
hypogonadism
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use